Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-01-16 10:31 CET (UTC+1h)
 

Regarding US FDA guidelines [Bioanalytics]

posted by sri - 2009-07-09 13:01  - Posting: # 3945
Views: 2,716

Dear all,
Please clarify me the below sentense which is present in 'Guidance for Industry Bioanalytical Method Validation'.

The calibration (standard) curve should cover the expected unknown sample concentration range in addition to a calibrator sample at lower limit of quantification.


Regards,
Sri

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,667 Posts in 3,778 Threads, 1,101 registered users;
25 users online (0 registered, 25 guests).

In matters of style, swim with the current;
in matters of principle, stand like a rock.    Thomas Jefferson

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed